With a decade of experimentation and heavy investment, the pressure is mounting for pharma to go big in digital health or retreat to its comfort zone in medicine. It’s obvious that pharma is ‘all in’ in digital health, but with high stakes, continued regulatory uncertainty, market access ambiguity, and commercial unknowns, scaling these solutions is imperative for pharma to stay in sync with the digital evolution of healthcare.
Scale requires local, national, and international collaboration, dedicated resource, IT skillsets typically outside of pharma’s remit, and an amplified patient and HCP voice (i.e., a brand-new customer engagement plan) to guarantee buy-in and adherence en masse.
This free Reuters Events webinar will bring together commercial and access leaders from pharma’s digital health organisations to break down barriers in digital health commercialisation and build the blueprint for scaling solutions effectively.
Join to discuss how you can:
• Develop a blueprint for scaling digital health pilots, to effectively demonstrate ROI and drive data/insights back into your commercial strategy
• Achieve large-scale, cross-regional patient and HCP engagement, to ensure multiple referral pathways and wide-spread buy-in
• Co-create the criteria and framework required with policymakers and payers, to bring digital health solutions to larger patient populations
• Embed interoperability as a key component of your commercial strategy, to resolve infrastructural issues plaguing the digital health value chain and scale-up bottlenecks
